ConductScience.org, home
The Safety and Efficacy of AlphaWave® L-Theanine on Adults Who Experience Moderate Stress on a Regular Basis
API referenceFor AI assistants

Trial · NCT05808595

Registered outcomes32

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

21 to 32 of 32

Download this page as JSON
ListOutcomeTime frameDescription
SecondaryMeasurement of estimated glomerular filtration rate (eGFR) following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of white blood cell count (WBC) with differential following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28WBC differentials include neutrophils, lymphocytes, monocytes, eosinophils, and basophils.
SecondaryMeasurement of red blood cell count (RBC) following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of hemoglobin following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of hematocrit following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of platelet count following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of immature granulocytes following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of nucleated red blood cells (RBC) following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of mean corpuscular volume (MCV) following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of mean corpuscular hemoglobin (MCH) following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of mean corpuscular hemoglobin concentration (MCHC) following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28
SecondaryMeasurement of red blood cell distribution width (RDW) following supplementation with AlphaWave® L-Theanine and Placebo.screening, day 28

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05808595/registered?page=2

API referenceFor AI assistants